Menu

The role of corticotropin-releasing hormone (CRH) family in tumors

Su-Qin Yi, Jia-Xing An, Cheng-Cheng Liao, Sha Lei, Hai Jin,  Bi-Guang Tuo

Abstract:

The corticotropin-releasing hormone (CRH) family is widely distributed among the central nervous system and peripheral tissues, such as the digestive, cardiovascular, immune, reproductive, endocrine systems. The CRH family members are widely involved in the regulation of human cell biological processes, immune response, and regulation of inflammatory processes that can affect the occurrence and development of tumors. At present, CRH family members and their receptors can be detected in many tumor tissues, and some people think that members of the CRH family may be potential tumor treatment targets as they can affect cellular processes, such as proliferation, migration, invasion, and apoptosis. However currently, there is no systematic introduction to the relationship between the CRH family and various tumors. This review introduces the molecular regulation of the CRH family in tumor formation and seeks further targeted therapy.

Received date: 02/19/2021

Accepted date: 08/31/2021

Ahead of print publish date: 09/17/2021

Issue: 5/2021

Volume: 68

Pages: 907 — 916

Keywords: CRH family, cancer, targeted therapy, mechanism

DOI: 10.4149/neo_2021_210219N226

Pubmed

Shopping cart is empty